Table 3. Table 3. Apoptosis and regeneration.
Age (months) | 6 | 12 | 18 | 24 | 30 | 36 | 42 |
Casp3 | 0(−) | 0(−) | 0(−) | 0(−) | 0.1(0–3) | 0.1(0–1.1) | 0.1(0–0.1) |
p-value | − | NA | NA | NA | 0.15 | 0.17 | 0.35 |
Ki67 | 0.9(0.6–2.9) | 0.8(0.4–1.1) | 1.1(0.7–2.0) | 0.5(0.3–1.3) | 0.7(0.1–1.0) | 2.3(0.1–4.4) | 2.1(1–4.6) |
p-value | − | 0.79 | 0.88 | 0.25 | 0.13 | 0.88 | 0.5 |
K19 | 1.9(1.2–3.2) | 2.5(1–3.3) | 3.2(2.7–3.4) | 1.8(1.5–3.3) | 3.7(2.5–5.3) | 3.6(2.8–7.4) | 5.2(4–9.6) |
p-value | − | 0.10 | 0.063 | 0.58 | 0.058 | 0.063 | 0.125 |
NA: not available.
Number of (active) caspase-3 (Casp3) positive hepatocytes per 10-times objective (manual count), number of Ki67 positive hepatocytes per 10-times objective (manual count), and number of K19 positive cells in the limiting plate per portal area in five COMMD1-deficient dogs in a time-dependent copper-induced hepatitis. Data are presented as median (range).
The uncorrected p-values for comparison of each time point with 6 months of age are reported in the table. No significant differences are present when correcting these p-values for the number of tests.